| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/10409238.2016.1173010 |
| P698 | PubMed publication ID | 27112431 |
| P2093 | author name string | Lori L Isom | |
| James Offord | |||
| P2860 | cites work | The Sequence of the Human Genome | Q22065842 |
| Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis | Q24323318 | ||
| KEGG: kyoto encyclopedia of genes and genomes | Q24515297 | ||
| A genome-wide Drosophila screen for heat nociception identifies α2δ3 as an evolutionarily conserved pain gene | Q24620790 | ||
| Pharmacological disruption of calcium channel trafficking by the alpha2delta ligand gabapentin | Q24656027 | ||
| A review of the preclinical pharmacology of tiagabine: a potent and selective anticonvulsant GABA uptake inhibitor | Q40412354 | ||
| Antiepileptic Drug Development: I. History and a Program for Progress | Q40943516 | ||
| The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel | Q41217429 | ||
| DGIdb: mining the druggable genome | Q41917589 | ||
| Control and plasticity of the presynaptic action potential waveform at small CNS nerve terminals | Q42065131 | ||
| Pregabalin is a potent and selective ligand for α(2)δ-1 and α(2)δ-2 calcium channel subunits | Q42732657 | ||
| Altered nociceptive response in mice deficient in the alpha(1B) subunit of the voltage-dependent calcium channel | Q43718152 | ||
| Gabapentin is not a GABAB receptor agonist | Q43826491 | ||
| Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex | Q43862497 | ||
| Gabapentin-mediated inhibition of voltage-activated Ca2+ channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression. | Q43919472 | ||
| The anticonvulsant gabapentin (neurontin) does not act through gamma-aminobutyric acid-B receptors. | Q44000793 | ||
| Gabapentin and vigabatrin increase GABA in the human neocortical slice | Q44036802 | ||
| Gabapentin inhibits presynaptic Ca(2+) influx and synaptic transmission in rat hippocampus and neocortex | Q44094143 | ||
| Anticonvulsant activity of pregabalin in the maximal electroshock-induced seizure assay in α2δ1 (R217A) and α2δ2 (R279A) mouse mutants. | Q44131981 | ||
| Increased cortical GABA concentrations in depressed patients receiving ECT. | Q44336422 | ||
| Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations | Q44480416 | ||
| Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells | Q44552598 | ||
| GABA in epilepsy: the pharmacologic basis | Q44563344 | ||
| 3-Alkyl-4-aminobutyric acids: the first class of anticonvulsant agents that activates L-glutamic acid decarboxylase | Q44852249 | ||
| GABAB receptors do not mediate the inhibitory actions of gabapentin on the spinal reflex in rats | Q45187432 | ||
| A microdialysis study on the mechanism of action of gabapentin | Q45852744 | ||
| Pharmacological characterization of standard analgesics on mechanical allodynia in streptozotocin-induced diabetic rats. | Q45932666 | ||
| The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil | Q46710939 | ||
| Activity profile of pregabalin in rodent models of epilepsy and ataxia | Q46842071 | ||
| Cloning and deletion mutagenesis of the alpha2 delta calcium channel subunit from porcine cerebral cortex. Expression of a soluble form of the protein that retains [3H]gabapentin binding activity | Q48022953 | ||
| Anxiolytic-like activity of pregabalin in the Vogel conflict test in α2δ-1 (R217A) and α2δ-2 (R279A) mouse mutants | Q48137005 | ||
| Localization of [3H]gabapentin to a novel site in rat brain: autoradiographic studies | Q48332179 | ||
| Characterisation of [3H]gabapentin binding to a novel site in rat brain: homogenate binding studies | Q48332188 | ||
| Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labeled by tritiated gabapentin | Q48369138 | ||
| Gabapentin inhibits calcium currents in isolated rat brain neurons | Q48423056 | ||
| Effects of phenytoin, carbamazepine, and gabapentin on calcium channels in hippocampal granule cells from patients with temporal lobe epilepsy | Q48475404 | ||
| Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain | Q48687083 | ||
| Neurochemical actions of gabapentin in mouse brain | Q48687872 | ||
| The effect of diazepam on spinal cord activities: possible sites and mechanisms of action. | Q52726720 | ||
| Antiepileptic drug actions. | Q54117694 | ||
| Newer-Generation Antiepileptic Drugs and the Risk of Major Birth Defects | Q57200393 | ||
| Voltage-gated calcium channels | Q28242997 | ||
| Effects of ablation of N- and R-type Ca(2+) channels on pain transmission | Q28586209 | ||
| Altered pain responses in mice lacking alpha 1E subunit of the voltage-dependent Ca2+ channel. | Q28586867 | ||
| Calcium channel alpha2delta subunits: differential expression, function, and drug binding | Q28646948 | ||
| Branched-chain amino acids and neurotransmitter metabolism: Expression of cytosolic branched-chain aminotransferase (BCATc) in the cerebellum and hippocampus | Q29037622 | ||
| Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA | Q29308572 | ||
| The druggable genome | Q29547361 | ||
| The benzodiazepine story | Q30052341 | ||
| Immunohistochemical localization of voltage-gated calcium channels in substantia nigra dopamine neurons | Q32027852 | ||
| Diagnosing the decline in pharmaceutical R&D efficiency | Q34257771 | ||
| How theories evolved concerning the mechanism of action of barbiturates | Q34315069 | ||
| Antiepileptic drug mechanisms of action | Q34394976 | ||
| Structure-activity relationships of pregabalin and analogues that target the alpha(2)-delta protein. | Q34407677 | ||
| HAMAP in 2013, new developments in the protein family classification and annotation system | Q34495199 | ||
| Identification of the alpha2-delta-1 subunit of voltage-dependent calcium channels as a molecular target for pain mediating the analgesic actions of pregabalin | Q34579804 | ||
| From basic science to blockbuster drug: the discovery of Lyrica | Q34756471 | ||
| MIPS: analysis and annotation of proteins from whole genomes | Q34933194 | ||
| Effects of yoga versus walking on mood, anxiety, and brain GABA levels: a randomized controlled MRS study | Q35034526 | ||
| Gene expression and functional annotation of the human and mouse choroid plexus epithelium | Q35082443 | ||
| Ligand screening using fluorescence thermal shift analysis (FTS). | Q35109808 | ||
| Auxiliary subunits: essential components of the voltage-gated calcium channel complex. | Q35172799 | ||
| The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. | Q35824087 | ||
| Cortical GABA levels in primary insomnia | Q35962689 | ||
| Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register | Q36142531 | ||
| Ziconotide, an intrathecally administered N-type calcium channel antagonist for the treatment of chronic pain | Q36277918 | ||
| Emerging anti-insomnia drugs: tackling sleeplessness and the quality of wake time | Q37177059 | ||
| Calorimetry and thermodynamics in drug design | Q37197972 | ||
| Calcium channel diversity: multiple roles of calcium channel subunits | Q37533066 | ||
| A new look at calcium channel α2δ subunits | Q37767819 | ||
| A Comparison of the Pharmacokinetics and Pharmacodynamics of Pregabalin and Gabapentin | Q37785529 | ||
| Mechanisms of action of antiseizure drugs | Q38039637 | ||
| The diverse therapeutic actions of pregabalin: is a single mechanism responsible for several pharmacological activities? | Q38104021 | ||
| Clinical pharmacology of vigabatrin | Q38671473 | ||
| The alpha2delta ligand gabapentin inhibits the Rab11-dependent recycling of the calcium channel subunit alpha2delta-2. | Q39652650 | ||
| An historical perspective on GABAergic drugs | Q39768840 | ||
| P433 | issue | 4 | |
| P921 | main subject | gabapentin | Q410352 |
| P304 | page(s) | 246-256 | |
| P577 | publication date | 2015-07-01 | |
| P1433 | published in | Critical Reviews in Biochemistry and Molecular Biology | Q5186661 |
| P1476 | title | Drugging the undruggable: gabapentin, pregabalin and the calcium channel α2δ subunit. | |
| P478 | volume | 51 |
| Q43075987 | Designing Safer Analgesics via μ-Opioid Receptor Pathways |
| Q91400353 | Effect of gabapentin on sleep patterns disturbed by epilepsy |
| Q91822705 | Reproducibility of a battery of human evoked pain models to detect pharmacological effects of analgesic drugs |
| Q47937429 | Synergistic Interaction of a Gabapentin- Mangiferin Combination in Formalin-Induced Secondary Mechanical Allodynia and Hyperalgesia in Rats Is Mediated by Activation of NO-Cyclic GMP-ATP-Sensitive K+ Channel Pathway. |
Search more.